Status:
COMPLETED
A Phase 2 Study of E6005 in Patients With Atopic Dermatitis
Lead Sponsor:
Organon and Co
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
20-64 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy and safety profiles of E6005 ointment in patients with atopic dermatitis compared to vehicle. The pharmacokinetic profile after topical applicatio...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Adults of both genders aged 20 to 64 years at the time when the written informed consent is obtained.
- Outpatients diagnosed with atopic dermatitis.
- Exclusion Criteria
- Patients with a present illness of Kaposi's varicelliform eruption, scabies, molluscum contagiosum, impetigo contagious, psoriasis, connective tissue disorder, collagen disorder or Netherton's syndrome, etc., which could have an effect on the pathological evaluation of the atopic dermatitis.
- Patients with active infection that requires oral or intravenous administration of antibiotics, antifungal or antivirus agent/s at baseline.
- Patients with advanced disease or abnormal laboratory tests that would possibly affect the safety of the subject or the implementation of this study.
Exclusion
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT01461941
Start Date
December 1 2011
End Date
January 1 2013
Last Update
June 3 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya, Aichi-ken, Japan
2
Urayasu-shi, Chiba, Japan
3
Fukuoka, Fukuoka, Japan
4
Asahikawa-shi, Hokkaido, Japan